Can Kremil S (sucralfate) cause hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Kremil S (Sucralfate) Cause Low Blood Pressure?

No, sucralfate does not cause hypotension—it is one of the safest antiulcer medications with minimal systemic effects because less than 5% is absorbed from the gastrointestinal tract. 1, 2

Safety Profile of Sucralfate

Sucralfate has an excellent safety record with virtually no cardiovascular effects:

  • Minimal systemic absorption: Only 3-5% of an oral dose is absorbed, with over 90% excreted unchanged in feces, which explains the absence of systemic side effects including hypotension 2

  • No reported hypotensive effects: In clinical trials involving over 2,000 patients, hypotension was not identified as an adverse effect 1

  • Most common side effects are local: The primary adverse effects are constipation (3-4% of patients), dry mouth (1%), and skin eruptions (0.6%)—none of which are cardiovascular in nature 1, 2

Mechanism Explains Safety

The drug works locally at the ulcer site rather than systemically:

  • Sucralfate binds to proteinaceous material at ulcer sites, forming a protective barrier without affecting gastric pH or causing systemic effects 2

  • It remains at gastric ulcer sites for up to 6 hours, exerting purely local effects 2

Clinical Context

Important caveat: If a patient taking sucralfate experiences hypotension, look for other causes:

  • Concurrent medications that actually do cause hypotension (beta-blockers, calcium channel blockers, diuretics, ACE inhibitors) 3

  • Underlying conditions such as gastrointestinal bleeding (which sucralfate is used to prevent), sepsis, or hypovolemia 4

  • Polypharmacy effects, particularly in elderly patients taking multiple cardiovascular medications 3

Special Population Consideration

The only significant concern with sucralfate is aluminum accumulation in renal failure patients with prolonged use, but this does not manifest as hypotension 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.